Verition Fund Management
ASTH icon

Verition Fund Management’s Astrana Health ASTH Stock Holding History

Verition Fund Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,555
Closed -$634K – 3699
2025
Q4 		$634K Sell
25,555
-4,524
-15% -$120K ﹤0.01% 2480
2025
Q3 		$853K Buy
30,079
+4,748
+19% +$129K ﹤0.01% 2657
2025
Q2 		$630K Buy
+25,331
New +$713K ﹤0.01% 2790
2025
Q1 		– Sell
-28,735
Closed -$906K – 3769
2024
Q4 		$906K Buy
28,735
+9,917
+53% +$471K ﹤0.01% 2118
2024
Q3 		$1.09M Sell
18,818
-6,915
-27% -$340K 0.01% 1829
2024
Q2 		$1.04M Buy
25,733
+19,166
+292% +$760K 0.01% 1644
2024
Q1 		$276K Buy
+6,567
New +$256K ﹤0.01% 2335
2022
Q4 		– Sell
-5,325
Closed -$208K – 2852
2022
Q3 		$208K Buy
+5,325
New +$244K ﹤0.01% 2472

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Verition Fund Management's ASTH Position: Q1 2026 in Review

Verition Fund Management sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 25,555 shares — an estimated $634K sold.

Verition Fund Management first reported a position in ASTH in Q3 2022 and held it in 8 quarters. The position peaked at $1.09M in Q3 2024. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Verition Fund Management reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 25,555 Astrana Health shares in Q1 2026, an estimated $634K.
  • Verition Fund Management first reported a position in Astrana Health in Q3 2022 and held it in 8 quarters.
  • Verition Fund Management's Astrana Health position peaked at $1.09M in Q3 2024.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.